Description
Product details
GLIMITERIS TRIO 0.2 Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg GLIMITERIS TRIO 0.2 is a combination medication containing Voglibose 0.2 mg, Glimepiride 3 mg, and Metformin Hydrochloride 500 mg. It is commonly prescribed for managing blood sugar levels in patients with type 2 diabetes mellitus. Voglibose helps reduce post-meal glucose spikes by inhibiting carbohydrate absorption in the intestine. Glimepiride stimulates insulin release from the pancreas, aiding glucose utilization by cells. Metformin improves insulin sensitivity and reduces liver glucose production. This triple action helps control blood sugar effectively. It is important to follow your healthcare provider's dosage instructions and monitor blood glucose levels regularly while using GLIMITERIS TRIO 0.2. For further information: Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 ORDER Now:
![TELAVINCE AF 25 is primarily indicated for:
Hypertension (High Blood Pressure): Effectively helps in lowering elevated blood pressure.
Cardiovascular Risk Reduction: Supports heart health and reduces the risk of heart attack, stroke, and other complications related to high blood pressure.
Patients requiring combination therapy: Ideal for individuals who need more than one antihypertensive agent for optimal blood pressure control.
Mechanism of Action:
TELAVINCE AF 25 combines two mechanisms for effective blood pressure management:
Telmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and thereby reducing blood pressure.
[AF Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.
This dual-action combination provides better efficacy than single-drug therapy while maintaining a favorable safety profile.
Dosage and Administration:
Recommended Dose: As prescribed by a healthcare professional, typically one tablet daily.
Route: Oral, with water.
Timing: Can be taken with or without food, preferably at the same time each day.
Adjustment: Dose may be adjusted based on individual response and tolerability.
Important: Always follow your doctor’s instructions. Do not change the dose or stop medication without medical advice.
Key Benefits of TELAVINCE AF 25:
Effective blood pressure control with dual-action therapy.
Reduces the risk of cardiovascular complications associated with hypertension.
Convenient once-daily dosing for better patient adherence.
Well-tolerated with minimal side effects.
Suitable for long-term use under medical supervision.
Safety and Precautions:
Inform your doctor if you have kidney disease, liver disease, or heart failure.
Pregnant or breastfeeding women should use only if recommended by a physician.
Avoid excessive use of potassium-containing salt substitutes.
Regular monitoring of blood pressure and kidney function is recommended.
Do not combine with other angiotensin receptor blockers (ARBs) unless prescribed.
Possible Side Effects:
While generally well-tolerated, some patients may experience:
Dizziness or lightheadedness
Fatigue or weakness
Mild swelling of ankles or feet
Nausea or headache
Seek immediate medical attention if you experience:
Severe allergic reactions
Swelling of face, lips, or throat
Difficulty breathing
Storage Instructions:
Store in a cool, dry place away from sunlight.
Keep out of reach of children and pets.
Do not use after the expiry date mentioned on the package.
Why Choose TELAVINCE AF 25:
Developed by Steris Healthcare Pvt. Ltd, a trusted pharmaceutical company.
Ensures quality, safety, and efficacy in every tablet.
Designed for patient convenience with once-daily dosing.
Backed by clinical research for effective hypertension management.
Disclaimer:
The information provided here is for educational purposes only. TELAVINCE AF 25 should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.](https://productimages.withfloats.com/tile/68e63e0d931b4d6a7310ae2a.png)
![TELAVINCE EM is primarily indicated for the management of:
Hypertension (High Blood Pressure): Helps in reducing elevated blood pressure effectively.
Cardiovascular Risk Reduction: Supports heart health and reduces the risk of stroke, heart attack, and related complications.
Patients requiring combination therapy: Suitable for individuals who need more than one antihypertensive for better blood pressure control.
Mechanism of Action:
TELAVINCE EM works through a dual mechanism to control blood pressure:
Telmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and reducing blood pressure.
[EM Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.
The combination ensures better efficacy than monotherapy while maintaining a favorable safety profile.
Dosage and Administration:
Recommended Dose: As prescribed by a healthcare professional, typically one tablet daily.
Route: Oral administration with water.
Timing: Can be taken with or without food, preferably at the same time each day.
Adjustment: Dose may be modified based on individual response and tolerability.
Important: Always follow your doctor’s instructions. Do not alter the dose or stop medication without medical advice.
Key Benefits of TELAVINCE EM:
Effective blood pressure control with dual-action therapy.
Reduces risk of cardiovascular events associated with hypertension.
Convenient once-daily dosing improves patient compliance.
Well-tolerated with a low incidence of side effects.
Suitable for long-term use under medical supervision.
Safety and Precautions:
Inform your doctor if you have kidney disease, liver disease, or heart failure.
Pregnant or breastfeeding women should avoid use unless advised by a physician.
Avoid excessive salt substitutes containing potassium.
Regular blood pressure and kidney function monitoring is recommended.
Do not use in combination with other angiotensin receptor blockers (ARBs) unless prescribed.
Possible Side Effects:
Although TELAVINCE EM is generally well-tolerated, some patients may experience:
Dizziness or lightheadedness
Fatigue or weakness
Mild swelling in ankles or feet
Nausea or headache
Seek immediate medical attention if you experience severe side effects such as difficulty breathing, swelling of face or throat, or severe allergic reactions.
Storage Instructions:
Store in a cool, dry place away from direct sunlight.
Keep out of reach of children and pets.
Do not use after the expiry date mentioned on the package.
Why Choose TELAVINCE EM:
Developed by Steris Healthcare Pvt. Ltd, a trusted name in pharmaceutical excellence.
Ensures quality, safety, and efficacy in every tablet.
Designed for optimal patient compliance with convenient dosing.
Backed by clinical research for managing hypertension effectively.
Disclaimer:
The information provided here is intended for educational purposes only. TELAVINCE EM should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.](https://productimages.withfloats.com/tile/68e63c1a4302b5c8207e2858.png)
